What is CorMedix's other noncash income (expense)?

CorMedix (CRMD) reported other noncash income (expense) of -$672K in Q1 2026.

How has CorMedix's other noncash income (expense) changed year-over-year?

CorMedix's other noncash income (expense) decreased by 1360.9% year-over-year, from -$46K to -$672K.

What does other noncash income (expense) mean?

This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.

CorMedix CRMD Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

ITG

Integer HoldingsITGR

-$716K+72.2%

Emergent BiosolutionsEBS

$3.9M-65.5%

ICU MedicalICUI

-$2.99M+67.6%

Mirum Pharmaceuticals, Inc.MIRM

$278K-21.9%

PfizerPFE

——

Merck & Co.MRK

——

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's other noncash income (expense)?: CorMedix (CRMD) reported other noncash income (expense) of -$672K in Q1 2026.
How has CorMedix's other noncash income (expense) changed year-over-year?: CorMedix's other noncash income (expense) decreased by 1360.9% year-over-year, from -$46K to -$672K.
What does other noncash income (expense) mean?: This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.